NUPLAZID Trademark

Trademark Overview

On Wednesday, September 23, 2015, a trademark application was filed for NUPLAZID with the United States Patent and Trademark Office. The USPTO has given the NUPLAZID trademark a serial number of 86766194. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, April 3, 2023. This trademark is owned by ACADIA Pharmaceuticals Inc.. The NUPLAZID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
nuplazid

General Information

Serial Number86766194
Word MarkNUPLAZID
Filing DateWednesday, September 23, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, April 3, 2023
Registration Number5096814
Registration DateTuesday, December 6, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements

Description of MarkThe mark consists of the wording "NUPLAZID" in stylized indigo letters with an orange triangle forming the dot over the letter "I".
Goods and ServicesPharmaceuticals preparations for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
Indication of Colors claimedThe color(s) indigo and orange is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 29, 2015
Primary Code005
First Use Anywhere DateTuesday, May 31, 2016
First Use In Commerce DateTuesday, May 31, 2016

Trademark Owner History

Party NameACADIA Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameACADIA Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameACADIA Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, January 11, 2016ASSIGNED TO EXAMINER
Saturday, September 26, 2015NEW APPLICATION ENTERED
Tuesday, September 29, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 30, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, January 22, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, January 12, 2016NON-FINAL ACTION WRITTEN
Tuesday, January 12, 2016NON-FINAL ACTION E-MAILED
Tuesday, January 12, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 22, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, January 22, 2016EXAMINERS AMENDMENT E-MAILED
Friday, January 22, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 26, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 23, 2016ASSIGNED TO LIE
Monday, February 29, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, October 11, 2016USE AMENDMENT FILED
Wednesday, April 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 26, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, October 31, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 1, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 6, 2016REGISTERED-PRINCIPAL REGISTER
Monday, April 3, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 23, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, April 3, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

nuplazid psychologic psychiatric diseases disorders genetic metabolic preparations prevention treatment neurologic